Is there emerging and compelling enough evidence to maintain patients on P2Y12i monotherapy (in lieu of aspirin) following completion of DAPT? 

Yes, a recent meta-analysis favors clopidogrel over aspirin for long-term therapy.

Also, studies are coming out suggesting a shorter duration of DAPT.

Here's one:

Choi et al., PMID 36169938